CIDRAP newsletters options
BioVersys AG has a pipeline of novel antibiotic candidates targeting unmet needs.
Vaccination rates among US children aged 5 to 17 years varied widely by race as of August 2022.
The CDC is testing the Canadian samples to see if they are genetically related to poliovirus samples from New York.
Concerns are growing about the impact of China's surge and about XBB.1.5, which is quickly gaining dominance in the US.
Ninety or more days after vaccination, mild adverse reactions occurred in about half of patients, but no serious adverse events.
The findings highlight the importance of appropriate empirical antibiotic selection.
Nonspecific symptoms affected well-being the most: fatigue, confusion or lack of concentration, and sleep disorders.
Unvaccinated, infected inmates had an estimated 36% risk of spreading the virus, compared with 28% among infected vaccinees.
The case-fatality rate among confirmed cases was high, at 11% and 12% for 2021 and 2022, respectively.
In the US, the proportion of the more transmissible XBB.1.5 Omicron subvariant virus rises sharply again.
Relative to rates at 1 month after the first lockdown ended, stress, anxiety, and depression rose by 2.5%, 13.9%, and 22.2%, respectively, by 15 months.
The total volume of anticoagulants and antiplatelet medications at US hospitals fell 43% at the onset of the pandemic.
Forty-four states reported very high (25) or high (19) flu activity, down from 48 the week before.
A Salmonella Typhimurium outbreak linked to alfalfa sprouts from Nebraska-based SunSprout Enterprises has so far sickened 15 people.
People who have COVID-19–related loss of smell may benefit from visual-olfactory training using patient-preferred essential oils.
One example: ertapenem-resistant Enterobacter cloacae increased significantly in children compared with adults.
Infections caused by C difficile and MRSA resulted in 1,743 premature deaths in Canada in 2019 and cost hospitals more than $91 million (USD).
The CDC recorded 466 mpox infections in transgender and gender-diverse adults, which made up 1.7% of adult cases.
Waiting at least 3 months post-infection to get a COVID-19 booster can maximize the increase in antibody levels.
The government said a key goal is controlling major human and animal pathogens and that the plan sets new targets for combatting AMR.
